Overall, our data support a role for TNFα in inducing RPE damage and suggest that inhibiting TNFα directly or indirectly via targeting NA sensing may provide therapeutic benefit for patients with retinal diseases associated with inflammation-driven RPE degeneration. The gene discussed is TNF; the disease is Abnormal retinal morphology.